Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA asks Sanofi, Regeneron to assess cholesterol drug's cognitive risks
FDA asks Sanofi, Regeneron to assess cholesterol drug's cognitive risks
FDA asks Sanofi, Regeneron to assess cholesterol drug's cognitive risks
Submitted by
admin
on March 7, 2014 - 3:55pm
Source:
Yahoo/Reuters
News Tags:
Sanofi
FDA
Regeneron
alirocumab
PCSK9 inhibitors
Headline:
FDA asks Sanofi, Regeneron to assess cholesterol drug's cognitive risks
Do Not Allow Advertisers to Use My Personal information
